for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

FDA removes boxed warning from Johnson & Johnson's diabetes drug

Aug 26 (Reuters) - The U.S. Food and Drug Administration on Wednesday removed boxed warning about amputation risk for Johnson & Johnson’s diabetes drug Invokana.

The agency's harshest warning was part of the label as the FDA saw the risk of amputations was very serious. ( bit.ly/3jeJnh6) (Reporting by Trisha Roy in Bengaluru; Editing by Sriraj Kalluvila)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up